ADULT VACCINES MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Detailed Segmentation-

• By Vaccines
  (Revenue, USD Bn, 2021 - 2033)

  • Influenza 
  • Tetanus, Diphtheria, Pertussis (Td/Tdap) 
  • Varicella 
  • Human Papillomavirus 
  • Zoster 
  • Measles, Mumps, Rubella (MMR) 
  • Pneumococcal 
  • Hepatitis 
  • Others

• By Vaccine Type
  (Revenue, USD Bn, 2021 - 2033)

  • Monovalent 
  • Multivalent   

• By Technology (Revenue, USD Bn, 2021 - 2033)

  • Live Attenuated Vaccines
  • Inactivated Viral/Bacterial Vaccines
  • Toxoid Vaccines
  • Recombinant Vaccines
  • Conjugate Vaccines

• Regional Insights (Revenue, USD Bn, 2021 - 2033)

  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa